These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 7736924

  • 1. Antipeptide antibodies targeted against specific regions of rat CYP2D1 and human CYP2D6.
    Laurenzana EM, Sorrels SL, Owens SM.
    Drug Metab Dispos; 1995 Feb; 23(2):271-8. PubMed ID: 7736924
    [Abstract] [Full Text] [Related]

  • 2. Antipeptide antibodies against overlapping sequences differentially inhibit human CYP2D6.
    Cribb A, Nuss C, Wang R.
    Drug Metab Dispos; 1995 Jul; 23(7):671-5. PubMed ID: 7587952
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of debrisoquin clearance in perfused rat livers and inhibition of dextromethorphan metabolism in human liver microsomes by 4-hydroxydebrisoquin or other metabolites of debrisoquin.
    Jaruratanasirikul S, Cooper AD, Blaschke TF.
    Drug Metab Dispos; 1992 Jul; 20(3):379-82. PubMed ID: 1355711
    [Abstract] [Full Text] [Related]

  • 4. Purification and characterization of a dog cytochrome P450 isozyme belonging to the CYP2D subfamily and development of its antipeptide antibody.
    Nakamura A, Yamamoto Y, Tasaki T, Sugimoto C, Masuda M, Kazusaka A, Fujita S.
    Drug Metab Dispos; 1995 Nov; 23(11):1268-73. PubMed ID: 8591729
    [Abstract] [Full Text] [Related]

  • 5. Affinity and potency of proinhibitory antipeptide antibodies against CYP2D6 is enhanced using cyclic peptides as immunogens.
    Schulz-Utermoehl T, Edwards RJ, Boobis AR.
    Drug Metab Dispos; 2000 May; 28(5):544-51. PubMed ID: 10772633
    [Abstract] [Full Text] [Related]

  • 6. Improved separation and immunodetection of rat cytochrome P450 4A forms in liver and kidney.
    Okita JR, Johnson SB, Castle PJ, Dezellem SC, Okita RT.
    Drug Metab Dispos; 1997 Aug; 25(8):1008-12. PubMed ID: 9280410
    [Abstract] [Full Text] [Related]

  • 7. Epitope mapping studies with human anti-cytochrome P450 3A antibodies.
    Leeder JS, Gaedigk A, Lu X, Cook VA.
    Mol Pharmacol; 1996 Feb; 49(2):234-43. PubMed ID: 8632755
    [Abstract] [Full Text] [Related]

  • 8. Characterization of a rat liver cytochrome P-450UT-H cDNA clone and comparison of mRNA levels with catalytic activity.
    Churchill PF, Churchill SA, Martin MV, Guengerich FP.
    Mol Pharmacol; 1987 Feb; 31(2):152-8. PubMed ID: 3543648
    [Abstract] [Full Text] [Related]

  • 9. Two monoclonal antibodies recognizing different epitopes on rat cytochrome IIB1 react with human IIE1.
    Wrighton SA, Vandenbranden M, Becker GW, Black SD, Thomas PE.
    Mol Pharmacol; 1992 Jan; 41(1):76-82. PubMed ID: 1370708
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Production of a form-specific, inhibitory antibody against rat cytochrome P450 2B1 using a synthetic peptide antigen against a putative substrate binding site.
    Charnecki J, Putt D, Kim EY, Kim H.
    Biochem Biophys Res Commun; 1995 Nov 22; 216(3):1024-33. PubMed ID: 7488175
    [Abstract] [Full Text] [Related]

  • 13. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
    Mani C, Gelboin HV, Park SS, Pearce R, Parkinson A, Kupfer D.
    Drug Metab Dispos; 1993 Nov 22; 21(4):645-56. PubMed ID: 8104124
    [Abstract] [Full Text] [Related]

  • 14. Regulation of two members of the steroid-inducible cytochrome P450 subfamily (3A) in rats.
    Cooper KO, Reik LM, Jayyosi Z, Bandiera S, Kelley M, Ryan DE, Daniel R, McCluskey SA, Levin W, Thomas PE.
    Arch Biochem Biophys; 1993 Mar 22; 301(2):345-54. PubMed ID: 7681660
    [Abstract] [Full Text] [Related]

  • 15. An evaluation of cytochrome P450 isoform activities in the female dark agouti (DA) rat: relevance to its use as a model of the CYP2D6 poor metaboliser phenotype.
    Barham HM, Lennard MS, Tucker GT.
    Biochem Pharmacol; 1994 Apr 20; 47(8):1295-307. PubMed ID: 8185638
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Identification and analysis of cytochrome P450IID6 antigenic sites recognized by anti-liver-kidney microsome type-1 antibodies (LKM1).
    Yamamoto AM, Cresteil D, Boniface O, Clerc FF, Alvarez F.
    Eur J Immunol; 1993 May 20; 23(5):1105-11. PubMed ID: 7682958
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.